Back to Agenda
Powering Up Communications: Improving the Information Exchange Between Patients and Industry
Session Chair(s)
Rebecca A. Vermeulen, RPh
Vice President, Global Patient Networks | PD Medical Affairs
Genentech, A Member of the Roche Group, United States
This session will educate providers in the pharmaceutical, biotechnology, and the device industries on how patients use information to make educated clinical treatment decisions. Attendees will learn how to improve information exchange between patients and industry.
This session has been developed by the DIA Medical Communications, Medical Science Liaison, and Patient Engagement Communities.
Learning Objective : Examine the informational needs of patients who seek support and rationale when reviewing clinical treatment options; Identify the trusted sources patients regularly consult when engaged in the clinical treatment decision making process; Discuss how efficient patient-clinician communication can translate into improved consumer support provided by industry.
Speaker(s)
FDA: Empowering Patients with Trusted Resources
Anna Fine, PharmD, MS
National Institutes of Health (NIH), United States
Interim Director for ClinicalTrials.gov
EMA Perspective
Sabine Haubenreisser, PhD, MSc
European Medicines Agency, Netherlands
Principal Scientific Administrator, Stakeholders and Communication Division
Patient Perspective
Stephen Mikita, JD
Clinical Trials Transformation Initiative (CTTI), United States
Lead Project Manager
Have an account?